Vanderbilt Health evaluating vaccine for C. difficile for people 65 and older | Vanderbilt Health News
NEW37 days ago|Discuss (0)|Health
Article written by Vanderbilt Health News
Vanderbilt Health is enrolling participants aged 65 and older for a Phase 3 clinical trial of an investigational vaccine against Clostridioides difficile. The trial aims to evaluate the vaccine's effectiveness in preventing a significant health care-associated infection that affects many older adults.
Read full story @ news.vumc.org/2026/08/11/c-diff-study-enrolling-patients-over-65-at-increased-risk-of-infection »
NewzGrade: 91 [A-]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
91A-
FDCBA
SPAG95
Coherent90
Objective95
Sourced90
Concise85
Graded by NewzGrade AI AI · provisional on August 11, 2026 at 03:34 PM
91A-
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 95 | 90 | 95 | 90 | 85 |
91A-grade breakdown
SPAG
95
Coherent
90
Objective
95
Sourced
90
Concise
85
The article meets high journalistic standards for news by clearly reporting on a clinical trial related to C. difficile vaccination, while maintaining objectivity and citing credible sources.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
